First line of biological drugs in rheumatoid arthritis: a medication persistence analysis.
CONCLUSION: The medication persistence was different between biological drugs. The rigorous follow-up of patients, by a multidisciplinary team, is important to enable the development of strategies for the adequate use of such drugs.
PMID: 30813823 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
More News: Abatacept | Actemra | Arthritis | Brazil Health | Drugs & Pharmacology | Enbrel | History of Medicine | Humira | Orencia | Remicade | Rheumatoid Arthritis | Rheumatology